Stéphane Bancel, Moderna CEO (Christopher Goodney/Bloomberg via Getty Images)
May 2, 2024 11:27 AM EDT
Pharma

Mod­er­na sticks to long-term strat­e­gy in first-quar­ter up­date, ends pact with Metageno­mi

Max Gelman

Senior Editor

Mod­er­na’s shift to a more “re­strained” pos­ture was on full dis­play Thurs­day morn­ing dur­ing its first-quar­ter earn­ings up­date.

CEO Stéphane Ban­cel and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Bridge­Bio shares promis­ing re­sults in tri­al of Cana­van dis­ease gene ther­a­py

CRISPR ther­a­py re­duces swelling at­tacks by 81% in In­tel­lia fol­low-up study

Fac­ing lost re­bates, MGM Re­sorts to stop cov­er­ing GLP-1 weight loss shots

Icon's quar­ter­ly earn­ings hit by biotech and phar­ma pull­back

Ex­clu­sive: Uni­ver­si­ty of Toron­to spin­out rais­es $53.5M to cre­ate new obe­si­ty drugs with AI

sponsored

IDEAYA Bio­sciences: Tar­get­ing un­met mar­ket needs with pre­ci­sion on­col­o­gy

A service from the Financial Times